000 01402 a2200385 4500
005 20250510212607.0
264 0 _c19751028
008 197510s 0 0 eng d
022 _a0069-0112
040 _aNLM
_beng
_cNLM
100 1 _aHorton, J
245 0 0 _aPhase II trials with procarbazine (NSC-77213), streptozotocin (NSC-85998), 6-THIOGUANINE (NSC-752), and CCNU (NSC-79037) in patients with metastatic cancer of the large bowel.
_h[electronic resource]
260 _bCancer chemotherapy reports
_c
300 _a333-40 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aClinical Trials as Topic
650 0 4 _aColonic Neoplasms
_xdrug therapy
650 0 4 _aDrug Evaluation
650 0 4 _aDrug Therapy, Combination
650 0 4 _aHumans
650 0 4 _aLomustine
_xadverse effects
650 0 4 _aNeoplasm Metastasis
650 0 4 _aNitrosourea Compounds
_xtherapeutic use
650 0 4 _aProcarbazine
_xadverse effects
650 0 4 _aStreptozocin
_xadverse effects
650 0 4 _aThioguanine
_xadverse effects
700 1 _aMittelman, A
700 1 _aTaylor, S G
700 1 _aJurkowitz, L
700 1 _aBennett, J M
700 1 _aEzdinli, E
700 1 _aColsky, J
700 1 _aHanley, J A
773 0 _tCancer chemotherapy reports
_gvol. 59
_gno. 2 Pt 1
_gp. 333-40
999 _c122927
_d122927